Chandler Robinson
Gründer bei MONOPAR THERAPEUTICS INC.
Vermögen: 104 164 $ am 30.04.2024
Profil
Chandler Drew Robinson is the founder of Monopar Therapeutics, Inc. (founded in 2014) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of Tactic Pharma LLC (founded in 2010) where he holds the title of Manager.
Currently, Dr. Robinson is the Director at Chemistry of Life Processes Institute.
In the past, he has worked as a Director at Wilson Therapeutics AB, Wilson Therapeutics, Inc., and Onyx Pharmaceuticals, Inc. He also held the position of Co-Manager-Healthcare Clinic at Onyx Pharmaceuticals, Inc. Prior to that, he worked as the President at The Bear Stearns Cos.
LLC.
Dr. Robinson's education includes a doctorate from Stanford University, an MBA from the University of Cambridge, an undergraduate degree from Northwestern University, and a graduate degree from the London School of Economics & Political Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MONOPAR THERAPEUTICS INC
0,95% | 31.03.2024 | 166 131 ( 0,95% ) | 104 164 $ | 30.04.2024 |
Aktive Positionen von Chandler Robinson
| Unternehmen | Position | Beginn |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Gründer | 01.12.2014 |
| Chemistry of Life Processes Institute | Direktor/Vorstandsmitglied | - |
Tactic Pharma LLC
 Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2010 |
Ehemalige bekannte Positionen von Chandler Robinson
| Unternehmen | Position | Ende |
|---|---|---|
The Bear Stearns Cos. LLC
 The Bear Stearns Cos. LLC Investment Banks/BrokersFinance Part of JPMorgan Chase & Co., The Bear Stearns Cos. LLC provides investment banking and securities dealing services. The private company is based in New York, NY. | Präsident | - |
| Wilson Therapeutics, Inc. | Direktor/Vorstandsmitglied | - |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
| WILSON THERAPEUTICS AB | Direktor/Vorstandsmitglied | - |
Ausbildung von Chandler Robinson
| Northwestern University | Undergraduate Degree |
| University of Cambridge | Masters Business Admin |
| Stanford University | Doctorate Degree |
| London School of Economics & Political Science | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MONOPAR THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
| Wilson Therapeutics, Inc. | |
Tactic Pharma LLC
Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Commercial Services |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
The Bear Stearns Cos. LLC
The Bear Stearns Cos. LLC Investment Banks/BrokersFinance Part of JPMorgan Chase & Co., The Bear Stearns Cos. LLC provides investment banking and securities dealing services. The private company is based in New York, NY. | Finance |
